{
  "id" : "extension_bbm",
  "algorithm" : "eod_public",
  "version" : "1.2",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "notes" : "**Note 1:** When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and extension information on the primary tumor are available, use the extension information to code primary tumor in preference to a statement of FIGO stage.\n\n**Note 2:** Genital metastasis (vagina, ovary, broad ligament, fallopian tube) is coded to 700. Any involvement of non-genital structures, whether by direct invasion or metastasis is coded in EOD Mets.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 631\n\n(6) Chen, L., Olawaiye, A.B., Mutch, D.G., et al. **Gestational Trophoblastic Neoplasms**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 691-697",
  "last_modified" : "2018-05-09T15:33:20.293Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "eod_2018_t",
    "name" : "EOD 2018 T",
    "type" : "ENDPOINT"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "In situ, intraepithelial, noninvasive", "VALUE:88", "VALUE:IS" ], [ "100", "Confined to placenta\n\nLocalized, NOS\n\nFIGO Stage 1", "VALUE:T1", "VALUE:L" ], [ "200", "Cervix\nCorpus uteri\nUterus, NOS", "VALUE:T1", "VALUE:RE" ], [ "300", "Adjacent connective tissue, NOS\n\nOther genital structure(s) by DIRECT EXTENSION or NOS\n- Broad ligament(s)\n- Fallopian tube(s)\n- Genital structure(s), NOS\n- Ovary(ies)\n- Vagina\n\nFIGO Stage II", "VALUE:T2", "VALUE:RE" ], [ "700", "Other genital structure(s) by METASTASIS\n- Broad ligament(s) \n- Cervix uteri\n- Corpus uteri\n- Fallopian tube(s)\n- Genital structure(s), NOS\n- Ovary(ies)\n- Uterus, NOS\n- Vagina\n\nFurther contiguous extension", "VALUE:T2", "VALUE:D" ], [ "800", "No evidence of primary tumor", "VALUE:T0", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed \nNot documented in patient record\n\nDeath Certificate Only", "VALUE:TX", "VALUE:U" ] ]
}